Predictors of outcome for renal artery stenting performed for salvage of renal function
- PMID: 21803522
- DOI: 10.1016/j.jvs.2011.04.042
Predictors of outcome for renal artery stenting performed for salvage of renal function
Abstract
Objective: To identify preoperative clinical features that predict a durable improvement in renal function with renal artery stenting (RAS).
Methods: Sixty-one patients with renal insufficiency (serum creatinine ≥ 1.5 mg/dL) underwent RAS for renal salvage. Patients were categorized as "responders" if estimated glomerular filtration rate (eGFR) at last follow-up was improved 20% or more over baseline. Patients with stable or worse renal function after RAS were labeled "non-responders." For the purpose of calculating changes in eGFR, patients on dialysis were represented by an eGFR of 10 ml/min/1.73 m(2). Renal volume was estimated as kidney length × width × depth/2.
Results: The median age of the cohort was 66 years (interquartile range [IQR], 60-73 years). Median preoperative serum creatinine was 1.8 mg/dL (IQR, 1.6-2.3), and median estimated glomerular filtration rate (eGFR) was 34 mL/min/1.73 m(2) (IQR, 24-45). With stenting, 17 of 61 patients (27.9%) derived a durable improvement in renal function at a median follow-up of 24 months (IQR, 16-33 months). The largest proportion of stented patients (44.3%) had no improvement in renal function after stenting, while a subset (27.9%) experienced a decline in renal function. Responders enjoyed a 47% improvement in renal function from baseline, while non-responders had a 13% decrement in renal function (P < .0001). Responders had a higher baseline serum creatinine, lower eGFR, and a steeper decline in renal function prior to RAS, compared with non-responders. Kidney length, width, depth, and volume were not significantly different between responders and non-responders. Logistic regression analysis identified the rate of decline of renal function prior to stenting as the only independent preoperative predictor of improved renal function after RAS (odds ratio, 3.4; 95% confidence interval, 1.6 to 7.5; P = .0019). The rate of decline in eGFR per week was more than 20-fold greater for responders than non-responders (2.1% vs 0% decline in eGFR per week; P < .0001). No predictors of renal function deterioration after stenting were identified.
Conclusions: The current study found that a steep decline in preoperative renal function portends a higher likelihood of renal salvage from RAS among patients with renal insufficiency. Incorporating this finding into patient selection may improve outcomes for RAS.
Published by Mosby, Inc.
Similar articles
-
Longitudinal changes in kidney parenchymal volume associated with renal artery stenting.J Vasc Surg. 2012 Mar;55(3):774-80; discussion 780. doi: 10.1016/j.jvs.2011.10.026. Epub 2012 Jan 21. J Vasc Surg. 2012. PMID: 22264697
-
Renal Salvage with Renal Artery Stenting Improves Long-term Survival.Ann Vasc Surg. 2017 Nov;45:106-111. doi: 10.1016/j.avsg.2017.05.033. Epub 2017 Jun 7. Ann Vasc Surg. 2017. PMID: 28602899
-
Endovascular revascularization of renal artery stenosis in the solitary functioning kidney.J Vasc Surg. 2009 Apr;49(4):953-60. doi: 10.1016/j.jvs.2008.11.042. Epub 2009 Feb 14. J Vasc Surg. 2009. PMID: 19217744
-
Renal angioplasty and stenting: is it still indicated after ASTRAL and STAR studies?J Cardiovasc Surg (Torino). 2010 Oct;51(5):701-20. J Cardiovasc Surg (Torino). 2010. PMID: 20924331 Review.
-
The management of renal artery stenosis: an alternative interpretation of ASTRAL and CORAL.Eur J Vasc Endovasc Surg. 2015 Apr;49(4):465-73. doi: 10.1016/j.ejvs.2014.12.026. Epub 2015 Feb 26. Eur J Vasc Endovasc Surg. 2015. PMID: 25725508 Review.
Cited by
-
Impact of Renal Function Trajectory on Renal Replacement Therapy and Mortality Risk after Renal Artery Revascularization.J Vasc Interv Radiol. 2020 Apr;31(4):592-597. doi: 10.1016/j.jvir.2019.07.025. Epub 2019 Sep 14. J Vasc Interv Radiol. 2020. PMID: 31530493 Free PMC article.
-
Mortality and Renal Replacement Therapy after Renal Artery Stent Placement for Atherosclerotic Renovascular Disease.J Vasc Interv Radiol. 2016 Aug;27(8):1215-24. doi: 10.1016/j.jvir.2016.05.001. Epub 2016 Jun 11. J Vasc Interv Radiol. 2016. PMID: 27296703 Free PMC article.
-
Early Rapid Decline in Kidney Function in Medically Managed Patients With Atherosclerotic Renal Artery Stenosis.J Am Heart Assoc. 2019 Jun 4;8(11):e012366. doi: 10.1161/JAHA.119.012366. Epub 2019 Jun 1. J Am Heart Assoc. 2019. PMID: 31433717 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous